Respiri Limited (RSH.AX)
AUD 0.03
(-6.06%)
AUD 0.03
(-6.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 3.55 Million AUD | 50.95% |
| 2023 | 2.35 Million AUD | 96.6% |
| 2022 | 1.19 Million AUD | -22.11% |
| 2021 | 1.53 Million AUD | -27.62% |
| 2020 | 2.12 Million AUD | -17.55% |
| 2019 | 2.57 Million AUD | 155.04% |
| 2018 | 1.01 Million AUD | 19.73% |
| 2017 | 843.65 Thousand AUD | -19.06% |
| 2016 | 1.04 Million AUD | -18.86% |
| 2015 | 1.28 Million AUD | -15.92% |
| 2014 | 1.52 Million AUD | 25.71% |
| 2013 | 1.21 Million AUD | 21.73% |
| 2012 | 998.39 Thousand AUD | -19.73% |
| 2011 | 1.24 Million AUD | -28.04% |
| 2010 | 1.72 Million AUD | 47.46% |
| 2009 | 1.17 Million AUD | 28.11% |
| 2008 | 914.91 Thousand AUD | 41.46% |
| 2007 | 646.75 Thousand AUD | 1801.33% |
| 2006 | 34.01 Thousand AUD | -58.0% |
| 2005 | 80.98 Thousand AUD | -50.22% |
| 2004 | 162.69 Thousand AUD | -89.22% |
| 2003 | 1.5 Million AUD | 30.3% |
| 2002 | 1.15 Million AUD | -27.54% |
| 2001 | 1.59 Million AUD | -41.11% |
| 2000 | 2.71 Million AUD | 142.16% |
| 1999 | 1.12 Million AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 3.55 Million AUD | 0.0% |
| 2024 Q2 | 2.73 Million AUD | 0.0% |
| 2024 FY | 3.55 Million AUD | 50.95% |
| 2023 FY | 2.35 Million AUD | 96.6% |
| 2023 Q2 | 1.03 Million AUD | 0.0% |
| 2023 Q4 | 2.35 Million AUD | 0.0% |
| 2022 Q2 | 1.9 Million AUD | 0.0% |
| 2022 Q4 | 1.19 Million AUD | 0.0% |
| 2022 FY | 1.19 Million AUD | -22.11% |
| 2021 FY | 1.53 Million AUD | -27.62% |
| 2021 Q2 | 1.3 Million AUD | 0.0% |
| 2021 Q4 | 1.53 Million AUD | 0.0% |
| 2020 FY | 2.12 Million AUD | -17.55% |
| 2020 Q4 | 2.12 Million AUD | 0.0% |
| 2020 Q2 | 1.72 Million AUD | 0.0% |
| 2019 Q4 | 2.57 Million AUD | 0.0% |
| 2019 FY | 2.57 Million AUD | 155.04% |
| 2019 Q2 | 2.2 Million AUD | 0.0% |
| 2018 Q4 | 1.01 Million AUD | 0.0% |
| 2018 Q2 | 946.36 Thousand AUD | 0.0% |
| 2018 FY | 1.01 Million AUD | 19.73% |
| 2017 Q2 | 842.45 Thousand AUD | 0.0% |
| 2017 Q4 | 843.65 Thousand AUD | 0.0% |
| 2017 FY | 843.65 Thousand AUD | -19.06% |
| 2016 FY | 1.04 Million AUD | -18.86% |
| 2016 Q2 | 1.31 Million AUD | 0.0% |
| 2016 Q4 | 1.04 Million AUD | 0.0% |
| 2015 Q2 | 1.43 Million AUD | 0.0% |
| 2015 FY | 1.28 Million AUD | -15.92% |
| 2015 Q4 | 1.28 Million AUD | 0.0% |
| 2014 Q4 | 1.52 Million AUD | 0.0% |
| 2014 Q2 | 2.39 Million AUD | 0.0% |
| 2014 FY | 1.52 Million AUD | 25.71% |
| 2013 Q4 | 1.21 Million AUD | 115.47% |
| 2013 FY | 1.21 Million AUD | 21.73% |
| 2013 Q1 | 357.51 Thousand AUD | -64.19% |
| 2013 Q2 | 964.01 Thousand AUD | 169.64% |
| 2013 Q3 | 564.03 Thousand AUD | -41.49% |
| 2012 Q4 | 998.39 Thousand AUD | 0.0% |
| 2012 FY | 998.39 Thousand AUD | -19.73% |
| 2011 FY | 1.24 Million AUD | -28.04% |
| 2011 Q4 | 1.24 Million AUD | 0.0% |
| 2010 FY | 1.72 Million AUD | 47.46% |
| 2010 Q4 | 1.72 Million AUD | 0.0% |
| 2009 FY | 1.17 Million AUD | 28.11% |
| 2009 Q4 | 1.17 Million AUD | 0.0% |
| 2008 FY | 914.91 Thousand AUD | 41.46% |
| 2008 Q4 | 914.91 Thousand AUD | 0.0% |
| 2007 Q4 | 646.75 Thousand AUD | 0.0% |
| 2007 FY | 646.75 Thousand AUD | 1801.33% |
| 2006 Q4 | 34.01 Thousand AUD | 0.0% |
| 2006 FY | 34.01 Thousand AUD | -58.0% |
| 2005 FY | 80.98 Thousand AUD | -50.22% |
| 2005 Q4 | 80.98 Thousand AUD | 0.0% |
| 2004 Q4 | 162.69 Thousand AUD | 0.0% |
| 2004 FY | 162.69 Thousand AUD | -89.22% |
| 2003 FY | 1.5 Million AUD | 30.3% |
| 2003 Q4 | 1.5 Million AUD | 0.0% |
| 2002 FY | 1.15 Million AUD | -27.54% |
| 2002 Q4 | 1.15 Million AUD | 0.0% |
| 2001 Q4 | 1.59 Million AUD | 0.0% |
| 2001 FY | 1.59 Million AUD | -41.11% |
| 2000 FY | 2.71 Million AUD | 142.16% |
| 1999 FY | 1.12 Million AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 92.76% |
| Adherium Limited | 3.4 Million AUD | -4.321% |
| Aroa Biosurgery Limited | 14.77 Million AUD | 75.952% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -174.567% |
| Anteris Technologies Ltd | 17.03 Million AUD | 79.142% |
| Control Bionics Limited | 2.75 Million AUD | -28.786% |
| CardieX Limited | 8.56 Million AUD | 58.493% |
| Compumedics Limited | 22.14 Million AUD | 83.954% |
| Cochlear Limited | 904.6 Million AUD | 99.607% |
| CleanSpace Holdings Limited | 6.94 Million AUD | 48.862% |
| Cyclopharm Limited | 13.65 Million AUD | 73.973% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | 34.857% |
| Nova Eye Medical Limited | 8.55 Million AUD | 58.443% |
| HeraMED Limited | 1.5 Million AUD | -135.997% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 85.787% |
| ImpediMed Limited | 6.24 Million AUD | 43.073% |
| InhaleRx Limited | 911.41 Thousand AUD | -289.941% |
| LBT Innovations Limited | 5.5 Million AUD | 35.476% |
| Micro-X Limited | 12.63 Million AUD | 71.87% |
| Neurotech International Limited | 314.69 Thousand AUD | -1029.325% |
| OncoSil Medical Limited | 1.98 Million AUD | -79.313% |
| PolyNovo Limited | 37.04 Million AUD | 90.406% |
| SomnoMed Limited | 24.78 Million AUD | 85.658% |
| Universal Biosensors, Inc. | 10.61 Million AUD | 66.512% |
| Uscom Limited | 2.07 Million AUD | -71.394% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | -28.446% |